Evidence map›Paper›PMID 35646676›Full record

ArticleFrontiers in oncology2022

Computed Tomography-Based Radiomics for Differentiation of Thymic Epithelial Tumors and Lymphomas in Anterior Mediastinum.

Wenzhang He, Chunchao Xia, Xiaoyi Chen, Jianqun Yu, Jing Liu, Huaxia Pu, Xue Li, Shengmei Liu, Xinyue Chen, Liqing Peng

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. CT radiomics and human-machine hybrid system for differentiating mediastinal lymphomas from thymic epithelial tumors.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Wenzhang HeDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Chunchao XiaDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Xiaoyi ChenDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Jianqun YuDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Jing LiuDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Huaxia PuDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Xue LiDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Shengmei LiuDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Xinyue ChenComputed Tomography (CT) Collaboration, Siemens Healthineers, Chengdu, China.
Liqing PengDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Sichuan University · CNWest China Hospital of Sichuan University · CNSiemens Healthcare (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the differential diagnostic performance of computed tomography (CT)-based radiomics in thymic epithelial tumors (TETs) and lymphomas in anterior mediastinum. Methods: There were 149 patients with TETs and 93 patients with lymphomas enrolled. These patients were assigned to a training set (n = 171) and an external validation set (n = 71). Dedicated radiomics prototype software was used to segment lesions on preoperative chest enhanced CT images and extract features. The multivariable logistic regression algorithm was used to construct three models according to clinico-radiologic features, radiomics features, and combined features, respectively. Performance of the three models was compared by using the area under the receiver operating characteristic curves (AUCs). Decision curve analysis was used to evaluate clinical utility of the three models. Results: For clinico-radiologic model, radiomics signature model, and combined model, the AUCs were 0.860, 0.965, 0.975 and 0.843, 0.961, 0.955 in the training cohort and the test cohort, respectively (all Conclusions: Radiomics signature model and combined model exhibit outstanding and comparable differential diagnostic performances between TETs and lymphomas. The CT-based radiomics analysis might serve as an effective tool for accurately differentiating TETs from lymphomas before treatment.

Indexed as

anterior mediastinumcomputed tomographylymphomaradiomicsthymic epithelial tumors

Identifiers

PMID35646676
PMCPMC9136168
OpenAlexW4280506004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.